Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2003
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003WO2003074514A1 Alkylammonium salts of omeprazole and esomeprazole
09/12/2003WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074498A1 Cyclic compound, process for producing the same, and pest control agent
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074490A1 9-aminoacridine derivatives and process for the preparation thereof
09/12/2003WO2003074484A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074053A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003WO2003074047A1 Indole derivatives as modulators of potassium channels
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003WO2003045940A3 Benzazepine derivatives and their use as 5-ht ligands
09/12/2003WO2003029243A3 2-aryloxy-6-pyrazolyl-pyridines
09/12/2003WO2002060871A3 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002056884A3 Treatment of malaria with farnesyl protein transferase inhibitors
09/12/2003CA2706618A1 Quinoline derivatives
09/12/2003CA2478618A1 Isoquinoline derivatives
09/12/2003CA2477717A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477403A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/11/2003WO2003074511A1 Quinoline derivatives
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003WO2003074493A1 5-substituted-alkylaminopyrazole derivatives as pesticides
09/11/2003WO2003074492A2 5-substituted-alkylaminopyrazole derivatives as pesticides
09/11/2003WO2003074056A1 Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered orally
09/11/2003US20030171591 Process for producing optically active sulfoxide derivative
09/11/2003US20030171588 And 3-carboxylic acids and derivatives; preparation from a resin bound aldehyde or diamine
09/11/2003US20030171461 Process for the synthesis of amine ethers from secondary amino oxides
09/11/2003US20030171413 Rheumatic diseases; antiarthritic agents; asthma
09/11/2003US20030171410 2-pyridylmethylamine derivatives useful as fungicides
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171403 Blockade of voltage dependent sodium channels
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171386 Small molecules for the treatment of abnormal cell growth
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171378 Indolinone derivatives
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus
09/11/2003US20030171369 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
09/11/2003US20030171368 Compounds which bind to integrin receptors; treatment of thromboembolic events, cardiovascular diseases, pulmonary diseases, tumors, gastrointestinal diseases
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171360 Piperidines
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171218 Substituted 3-heteroaryl(amino- or oxy) pyrrolidin-2-ones of the formula (I), processes for preparing them, and their use as herbicides or as plant growth regulators.
09/11/2003US20030170174 For therapy of diseases, such as parasitic and viral infections, conditions associated with inflammation and infection, and conditions mediated by cell-proliferation or collagen formation; contrast agents
09/10/2003EP1342719A1 Benzodiazepine derivatives useful as CCK-Receptor Antagonists
09/10/2003EP1341784A2 Process for making a thrombin inhibitor
09/10/2003EP1341783A1 Isoquinoline derivatives useful in the treatment of cns disorders
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341781A1 Antimicrobial quinolones
09/10/2003EP1341780A2 Substituted heterocyclic phthalic acid diamide arthropodicides
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341772A2 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341766A1 Imidazolone derivatives for the treatment of viral diseases
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
09/10/2003EP1341759A2 3-substituted oxindole beta 3 agonists
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1259522B1 Ligand and complex for catalytically bleaching a substrate
09/10/2003EP1187856B1 Transition metal complexes and olefin polymerization process
09/10/2003EP1140899B1 Process for preparing tricyclic compounds having antihistaminic activity
09/10/2003EP1131321B1 Indole derivatives and their use as serotonin receptor ligands
09/10/2003EP1037633B1 Antiviral compounds
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0912570B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441789A Piperazinedione compounds
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441784A Thrombin inhibitors comprising aminoisoquinoline group
09/10/2003CN1441783A Medicine comprising dicyanopyridine derivative
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441780A Piperidine compounds for use as CCR-3 inhibitors
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1440962A Substituted amino amide salicylate with Fungal killing function and tis prepared intermediate thereof
09/09/2003US6617347 Selective β3 adrenergic agonists
09/09/2003US6617338 Condensation of omeprazole, lansoprazole or pantoprazole with an addition copolymer having acrylonitrile, acrylic ester or aromatic olefin monomers, to form the polymer conjugate; improved bioavailability
09/09/2003US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders
09/09/2003US6617332 Cyclic amidinourea derivatives
09/09/2003US6617325 Biphenyl derivatives, production thereof and uses as medicines
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/09/2003US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril
09/09/2003US6617317 Boronic ester and acid compositions
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 1080